These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 8986010

  • 1. Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine.
    von Moltke LL, Greenblatt DJ, Duan SX, Schmider J, Kudchadker L, Fogelman SM, Harmatz JS, Shader RI.
    Psychopharmacology (Berl); 1996 Dec; 128(4):398-407. PubMed ID: 8986010
    [Abstract] [Full Text] [Related]

  • 2. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
    Ball SE, Ahern D, Scatina J, Kao J.
    Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822
    [Abstract] [Full Text] [Related]

  • 3. O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressants.
    Fogelman SM, Schmider J, Venkatakrishnan K, von Moltke LL, Harmatz JS, Shader RI, Greenblatt DJ.
    Neuropsychopharmacology; 1999 May; 20(5):480-90. PubMed ID: 10192828
    [Abstract] [Full Text] [Related]

  • 4. Involvement of CYP2E1 as A low-affinity enzyme in phenacetin O-deethylation in human liver microsomes.
    Kobayashi K, Nakajima M, Oshima K, Shimada N, Yokoi T, Chiba K.
    Drug Metab Dispos; 1999 Aug; 27(8):860-5. PubMed ID: 10421611
    [Abstract] [Full Text] [Related]

  • 5. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA, Tjia JF, Back DJ.
    Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Terfenadine-antidepressant interactions: an in vitro inhibition study using human liver microsomes.
    Jurima-Romet M, Wright M, Neigh S.
    Br J Clin Pharmacol; 1998 Mar; 45(3):318-21. PubMed ID: 10896409
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants.
    von Moltke LL, Greenblatt DJ, Court MH, Duan SX, Harmatz JS, Shader RI.
    J Clin Psychopharmacol; 1995 Apr; 15(2):125-31. PubMed ID: 7782485
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. N-demethylation of amitriptyline in vitro: role of cytochrome P-450 3A (CYP3A) isoforms and effect of metabolic inhibitors.
    Schmider J, Greenblatt DJ, von Moltke LL, Harmatz JS, Shader RI.
    J Pharmacol Exp Ther; 1995 Nov; 275(2):592-7. PubMed ID: 7473143
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory monoclonal antibodies to human cytochrome P450 1A2: analysis of phenacetin O-deethylation in human liver.
    Yang TJ, Sai Y, Krausz KW, Gonzalez FJ, Gelboin HV.
    Pharmacogenetics; 1998 Oct; 8(5):375-82. PubMed ID: 9825829
    [Abstract] [Full Text] [Related]

  • 16. Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine.
    Rasmussen BB, Maënpää J, Pelkonen O, Loft S, Poulsen HE, Lykkesfeldt J, Brøsen K.
    Br J Clin Pharmacol; 1995 Feb; 39(2):151-9. PubMed ID: 7742153
    [Abstract] [Full Text] [Related]

  • 17. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.
    Bourrié M, Meunier V, Berger Y, Fabre G.
    J Pharmacol Exp Ther; 1996 Apr; 277(1):321-32. PubMed ID: 8613937
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo.
    von Moltke LL, Greenblatt DJ, Cotreau-Bibbo MM, Duan SX, Harmatz JS, Shader RI.
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1278-83. PubMed ID: 8138941
    [Abstract] [Full Text] [Related]

  • 19. Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high affinity component as an index of CYP1A2 activity.
    Venkatakrishnan K, von Moltke LL, Greenblatt DJ.
    J Pharm Sci; 1998 Dec; 87(12):1502-7. PubMed ID: 10189256
    [Abstract] [Full Text] [Related]

  • 20. The effect of tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) and newer antidepressant drugs on the activity and level of rat CYP3A.
    Haduch A, Wójcikowski J, Daniel WA.
    Eur Neuropsychopharmacol; 2006 Apr; 16(3):178-86. PubMed ID: 16246530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.